Back
Portman Ridge Finance Vs. Viking Therapeutics Industry Stock Comparison
Sell
48
PTMN
Portman Ridge Finance
Last Price:
18.51
Seasonality Move:
0.43%
Sell
43
VKTX
Viking Therapeutics
Last Price:
64.63
Seasonality Move:
38.04%
Sell
48
Portman Ridge Finance (PTMN)
is a Sell
Is Portman Ridge Finance a Buy, Sell or Hold?
- The current Portman Ridge Finance [PTMN] share price is $18.61. The Score for PTMN is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- PTMN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $64.63. The Score for VKTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTMN Stock Price Chart
What is Portman Ridge Finance's stock price today?
-
The Portman Ridge Finance share price today is $18.61
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTMN is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $64.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.
PTMN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Sell |
| Relative Strength Index (14 RSI): | 55.93 | Buy |
| Chaikin Money Flow: | 26714 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.23 - 18.51) | Buy |
| Bollinger Bands (100): | (18.31 - 19.43) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.41 | Buy |
| Relative Strength Index (14 RSI): | 46.54 | Sell |
| Chaikin Money Flow: | -1563854 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.12 - 71.48) | Sell |
| Bollinger Bands (100): | (53.04 - 66.68) | Buy |
PTMN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0 | Buy |
| 20-day SMA: | 0 | Buy |
| 50-day SMA: | 0 | Buy |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 0 | Buy |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 71.35 | Sell |
| 20-day SMA: | 67.56 | Sell |
| 50-day SMA: | 64.43 | Buy |
| 200-day SMA: | 60.03 | Buy |
| 8-day EMA: | 68.57 | Sell |
| 20-day EMA: | 67.8 | Sell |
| 50-day EMA: | 65.05 | Sell |
| 200-day EMA: | 55.42 | Buy |
Portman Ridge Finance Earnings Growth & PTMN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.44 per share, and an increase next year of $0.08 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Portman Ridge Finance Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||